News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Client Alert February 27, 2026
FTC Restarts Negative Option Rulemaking After Eighth Circuit Vacatur; Enforcement Under ROSCA Continues as Potential Scope of New Rule Remains in Flux
Until the scope of any new proposed rule becomes clear, companies should expect that cancellation design, consent flows, and subscription …
Client Alert February 27, 2026
Derivatives, Legislative and Regulatory Weekly Update (February 27, 2026)
Gibson Dunn lawyers bring you the latest in U.S. derivatives news from the past week.
Client Alert February 27, 2026
The CFTC Advises Prediction Market Users: Insider Information Is Not Fair Game
The CFTC re-affirms its intent to police insider trading on registered prediction markets. With prediction markets rapidly growing, the Commodity …
Accolades February 27, 2026
Lawdragon Names 32 Gibson Dunn Lawyers Among 500 Global Leaders in Crisis Management
Lawdragon has named 32 Gibson Dunn lawyers to its list of 500 Global Leaders in Crisis Management.
In the Media February 27, 2026
Angelique Kaounis Commentary Featured in IAM
The IAM (subscription required) article “UTSA v DTSA: How Claim Selection Is Steering Trade Secret Fight Dynamics” (February 26, 2025) features commentary by partner Angelique Kaounis.
Client Alert February 27, 2026
Less Form, More Substance: 10 Things You Need to Know About the Proposed UK Securitisation Reforms
This briefing summarises the key changes and their implications for originators, sponsors and original lenders involved in securitisation transactions, with …
Accolades February 27, 2026
Litigator of the Week Runners-Up and Shout-Outs
A team a Gibson, Dunn & Crutcher led by Harris Mufson secured an injunction for insurance client Marsh against U.K. broker Howden and seven former Marsh managers and account executives based in Florida who left to launch Howden’s Sunshine State operations.
Firm News February 27, 2026
Gibson Dunn Advised Shareholders in Connection with Sale of Aicuris to Asahi Kasei
Gibson Dunn advised the shareholders in connection with the sale of Aicuris Anti-infective Cures AG to Asahi Kasei, through its subsidiary Veloxis Pharmaceuticals, Inc.